James M. Mock - 11 Feb 2026 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Financial Officer
Signature: /s/ James Dillon, As Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 11 Feb 2026
Net transactions value: -$53,663
Form type: 4
Filing time: 13 Feb 2026, 16:41:15 UTC
Previous filing: 06 Jan 2026
Next filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mock James M	Chief Financial Officer	C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE	/s/ James Dillon, As Attorney-in-Fact	13 Feb 2026	0001736359

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Award	$0	+2,630	+6%	$0.000000	46,502	11 Feb 2026	Direct	F1
transaction	MRNA	Common Stock	Tax liability	$53,663	-1,278	-2.7%	$41.99	45,224	11 Feb 2026	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on February 28, 2023 (the "2023 PSUs").
F2	Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2023 PSUs.